G.-Y. Qing, T.-L. Sun, F. Wang, Y.-B. He, X. Yang
FULL PAPER
0.015, CHCl ). IR (KBr): ν = 3349, 1716, 1659, 1522, 1439, 1384,
Compound 6a: 0.28 g was obtained as a filemot powder (81% yield);
˜
3
1373, 1311, 1231, 1179, 1054, 835, 776 cm–1. H NMR (600 MHz,
m.p. 172–174 °C. [α]2D0 = +30.0 (c = 0.005, DMSO). IR (KBr): ν =
1
˜
CDCl3): δ = 1.39 (s, 3 H, CCH3), 1.41 (s, 3 H, CCH3), 3.82 (s, 6 3322, 1634, 1594, 1540, 1510, 1382, 1334, 1303, 1263, 1111, 853
H, OCH3), 4.35 (s, 2 H, Cp-H), 4.55 (s, 2 H, Cp-H), 4.76 (s, 2 H,
cm–1. 1H NMR (600 MHz, [D6]DMSO): δ = 1.25–1.29 (m, 6 H,
Cp-H), 4.81–4.89 (m, 2 H, C*H), 4.91 (s, 2 H, Cp-H), 7.75 (d, J = CH3), 2.70–2.81 (m, 2 H, NCH2C), 2.85–2.92 (m, 2 H, NCH2C),
8.4 Hz, 2 H, CONH) ppm. C20H24FeN2O6 (444.27): calcd. C 54.07, 3.57–3.62 (m, 4 H, NCH2C), 4.25 (s, 2 H, Cp-H), 4.30 (s, 2 H, Cp-
H 5.45, N 6.31; found C 53.82, H 5.57, N 6.20.
H), 4.38 (s, 2 H, Cp-H), 4.70–4.78 (m, 2 H, C*H), 4.84 (s, 2 H,
Cp-H), 7.31 (d, J = 7.2 Hz, 2 H, CONH), 7.75 (s, 4 H, NO2ArH),
7.97 (s, 2 H, CNHCS), 8.17 (s, 4 H, NO2ArH), 8.44 (s, 2 H,
CSNHAr), 10.20 (s, 2 H, CONHC) ppm. 13C NMR (150 MHz,
[D6]DMSO): δ = 18.1, 38.7, 44.1, 48.9, 70.4, 71.6, 72.1, 77.1, 121.3,
123.0, 124.2, 125.2, 125.7, 142.6, 144.1, 145.7, 146.7, 169.3, 175.1,
181.0 ppm. ESI-MS: m/z (%)
C36H40FeN10O8S2 (860.74): calcd. C 50.24, H 4.68, N 16.27; found
C 50.01, H 4.90, N 16.40.
The characterization data of compounds 2b–2d are listed in part
2.1 of the Supporting Information.
General Procedure for the Synthesis of the Fc Derivatives 3: A solu-
tion (20 mL) of 2a–2d (0.5 mmol) in CH3OH was added dropwise
to a stirred solution of hydrazine hydrate (6 equiv. for 2a–2d) in
CH3OH (10 mL). The mixture was stirred for 48 h under N2 pro-
tection at room temperature. The solvent was removed under re-
duced pressure, and water (50 mL) was poured into the residue.
The solid obtained was filtered and washed with cold CH3CH2OH
several times and dried in vacuo to obtain the pure product.
= 861.9 (100) [M +
H]+.
The characterization data of compounds 5b–5d, 6b–6d and 7a–7b
were listed in parts 2.4 and 2.5 of the Supporting Information,
respectively.
Compound 3a: 0.12 g was obtained as a brown powder (54% yield);
the compound decomposed at 196–198 °C. [α]2D0 = +87.2 (c = 0.005,
Bu4N+ Salts: Bu4N+ salts of the amino acids were prepared by
adding 2 equiv. of Bu4NOH in CH3OH to a solution of corre-
sponding N-protected aspartic acid or glutamic acid (1 equiv.) in
CH3OH. The mixture was stirred at room temperature for 2 h, and
the solvents were evaporated to dryness under reduced pressure.
The resulting syrup was dried under high vacuum at 50 °C for 24 h,
checked by NMR and stored in a desiccator.
DMSO). IR (KBr): ν = 3442, 3262, 1661, 1569, 1541, 1458, 1377,
˜
1315, 1276, 1202, 970 cm–1. ESI-MS: m/z (%) = 445.3 (100) [M +
H]+. C18H24FeN6O4 (444.27): calcd. C 48.66, H 5.44, N 18.92;
found C 48.35, H 5.60, N 18.74.
The characterization data of compounds 3b–3d were listed in part
2.2 of the Supporting Information.
Binding Studies: The host compounds were prepared as stock solu-
tions in DMSO at 5ϫ10–4 moldm–3. The anion was dissolved to
approximately 0.015 moldm–3 and 0.15 moldm–3 of stock solution
in DMSO. The working solutions were prepared by adding dif-
ferent volumes of N-protected aspartate or glutamate solution to a
series of test tubes followed by the addition of the same amount of
stock solution of host compound followed by dilution to 3.0 mL
by DMSO. After being shaken for several minutes, the work solu-
tion was measured immediately. KA values were calculated by
means of a nonlinear, least-squares, curve-fitting method with
ORIGIN 7.0 (Origin-Lab Corporation).
General Procedure for the Synthesis of the Fc Derivatives 4: A solu-
tion (20 mL) of 2a–2d (0.5 mmol) in CH3OH was added dropwise
to a stirred solution of ethylenediamine (6 equiv. for 2a–2d) in
CH3OH (10 mL). The mixture was stirred for 48 h under N2 pro-
tection at room temperature. The solvent and excess ethylenedi-
amine were removed under reduced pressure, and the residue was
washed with cold CH3CH2OH and dried in vacuo to give pure
product.
Compound 4a: 0.18 g was obtained as a filemot powder (72% yield);
the compound decomposed at 220 °C. [α]2D0 = +97.0 (c = 0.005,
DMSO). IR (KBr): ν = 3289, 3083, 2936, 1665, 1622, 1556, 1458,
˜
Supporting Information (see also the footnote on the first page of
this article): Scheme of the possible charge transfer process of com-
pounds 3a–3c, 1H NMR spectra of 3d and the characterization
data of reference compounds.
1380, 1316, 1199, 1036, 814 cm–1. 1H NMR (600 MHz, [D6]-
DMSO): δ = 1.26–1.31 (m, 6 H, CCH3), 1.75 (s, 4 H, D2O-exchang-
able, NH2), 2.98–3.16 (m, 8 H, NCH2CH2N), 4.31 (s, 2 H, Cp-H),
4.38 (s, 2 H, Cp-H), 4.46 (s, 2 H, Cp-H), 4.71–4.79 (m, 2 H, C*H),
4.91 (s, 2 H, Cp-H), 7.35 (d, J = 8.4 Hz, 2 H, CONH), 8.66 (s,
2 H, CONHC) ppm. ESI-MS: m/z (%) = 501.5 (100) [M + H]+. Acknowledgments
C22H32FeN6O4 (500.38): calcd. C 52.81, H 6.45, N 16.80; found C
52.57, H 6.58, N 16.72.
We thank the National Natural Science Foundation of China
(Grant No. 20572080), Alexander von Humboldt (AvH) Founda-
tion and the Federal Ministry of Education and Research of Ger-
many (BMBF) for fund support (Sofja Kovalevskaja Award pro-
ject).
The characterization data of compounds 4b–4d were listed in part
2.3 of the Supporting Information.
General Procedure for the Synthesis of the Fc Derivatives 5 and 6:
A solution of p-nitrophenyl isothiocyanate (0.144 g, 0.8 mmol) in
dry DMF (15 mL) was added dropwise to a solution of 3 or 4
(0.4 mmol) in dry DMF (15 mL) at room temperature. The reaction
mixture was then stirred at room temperature for 48 h. A large
amount of water was poured into the solution. The collected pre-
cipitate was washed with CHCl3 and acetone, and the solid was
dried under vacuum to obtain the pure product.
[1] a) J. M. Lehn, Supramolecular Chemistry. Concepts and Per-
spectives, VCH Verlagsgesellschaft, Weinheim, Germany, 1995;
b) K. Naemura, Y. Tobe, T. Kaneda, Coord. Chem. Rev. 1996,
148, 199–219; c) Y. Murakami, J. Kikuchi, Y. Hisaeda, O. Hay-
ashida, Chem. Rev. 1996, 96, 721–758; d) R. M. Izatt, K. Paw-
lak, J. S. Bradshaw, R. L. Bruening, Chem. Rev. 1995, 95, 2529–
2586.
[2] a) P. A. Gale, S. E. García-Garrido, J. Garric, Chem. Soc. Rev.
2008, 37, 151–190; b) L. Pu, Chem. Rev. 2004, 104, 1687–1716;
c) S. Ivan, Z. Petra, Top. Curr. Chem. 2005, 255, 31–63.
[3] a) G. J. Siegel, B. W. Agranoff, R. W. Albers, P. B. Molinoff,
Basic Neurochemistry: Molecular, Cellular and Medical Aspects,
5th ed., Raven, New York, 1994, pp. 267–387; b) J. I. Yeh, H. P.
Compound 5a: 0.19 g was obtained as a bottle-green powder (59%
yield); m.p. 168–170 °C. [α]2D0 = +116.1 (c = 0.005, DMSO). IR
(KBr): ν = 3331, 1630, 1595, 1547, 1506, 1384, 1332, 1301, 1247,
˜
1181, 1113, 851, 748 cm–1. ESI-MS: m/z (%) = 804.3 (100) [M+].
C32H32FeN10O8S2 (804.64): calcd. C 47.75, H 4.01, N 17.41; found
C 47.50, H 4.28, N 17.26.
848
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 841–849